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Abstract 
Injuries to the anterior cruciate ligament (ACL) and the meniscus are very common. Both the 
ACL and the meniscus play a crucial role in the complex biomechanics of the knee and 
operative treatment is often necessary. For example, in the US approximately 200,000 ACL 
reconstructions are performed annually. Usually, autogenous tendons like the mid- third of 
the patellar tendon or the hamstring tendons (semitendinosus/gracilis) are used. 
Nevertheless, the availability of autogenous tendons for ACL reconstruction is limited as 
well as the possibilities of meniscus repair. Ligament and meniscus allografts often show 
problems regarding long-term stability, immunological reactions and possible transmission 
of infectious diseases, whereas synthetic materials can cause foreign body reactions and 
often lack good initial biomechanical stability or fail to maintain long-term stability.  
The idea of acellularizing ligaments and meniscus cartilage has arisen to remove the 
immunogenic cells to reduce the adverse immunological reactions. By preserving the 
extracellular matrix (e. g. collagen, glycosaminoglycans, proteoglycans), the main 
biomechanical properties are preserved and the so obtained scaffolds provide a natural 
environment for the ingrowing cells. The acellular scaffolds can be used as a scaffold for in 
vivo repopulation or can be seeded with autologous cells in vitro before implantation using 
different cell sources. By this, further improvement of the biochemical and biomechanical 
properties as well as the remodelling of the graft could be improved. 
In the meantime, a variety of different methods has been described to acellularize tissues 
reaching from repetitive freezing/ thawing over the use of hydrostatic high pressure to 
different chemical methods. Only by chemical means are the cells actually removed. In 
terms of chemical acellularization, SDS (sodium dodecyl sulphate), Triton-X or TnbP (tri-
nitro-butyl-phosphate) are the most popular substances, with SDS being the strongest cell 
removal agent for tendon and meniscus tissue. As in vitro tests have shown, tissue 
processing using SDS does not influence the biomechanical properties, while all cells - being 
responsible for the immunological effects - are removed. However, more research using in 
vivo animal experiments has to be performed before application in humans is possible. 
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This tissue engineering strategy might be suitable to satisfy the increasing demand for tissue 
engineered tissue coming along with the increased patients´ demands in the future. 
 
1. Introduction 
Injuries to the ACL and the meniscus are very common and negatively influence the 
complex biomechanics of the knee joint. Due to the poor vascularity, both structures show 
limited healing capacity and surgical repair is often necessary (Arnozcky 1983, Arnozcky 
1983). In the US approximately 200,000 ACL reconstructions are performed per year and the 
number is still growing. The golden standard is the reconstruction of the injured ACL by 
using autogenous tendons like the hamstring tendons (semitendinosus/gracilis) or the 
middle- third of the patellar or quadriceps tendon. These methods have been used for 
several years now and show reliable results in the long- term. However, the problem of 
development of osteoarthrosis in the long term is not solved yet (Lohmander 2007, Messmer 
1999). So far no study exists proving a chondro-protective effect after ACL reconstruction. 
The reported outcome 32 years after ACL replacement is unacceptable in about 50% of cases. 
In accompanying meniscus lesions the outcome is even worse (Taylor 2009). Whether this is 
mainly due to cartilage injury at the time of accident or due to altered joint biomechanics is 
not known yet. So far, there exists no clear consensus, which patients benefit from ACL 
replacement in the long run. New techniques of ACL reconstruction like the anatomic 
double-bundle reconstruction (anteromedial and posterolateral bundle) and new methods of 
fixation might improve the outcome in the future (Kondo 2008, Zantop 2008, Brucker 2006).  
Though the ACL reconstruction using autogenous tendons is currently the gold standard, 
some problems still remain. There is on the one hand the problem of donor site morbidity 
with persisting anterior knee pain and the inability to kneel, especially after the use of 
patellar tendon transplants (Kartus 2001). Muscle strength deficits have been found after 
ACL reconstruction with patellar and hamstring grafts (Aune et al. 2001; Beard et al. 2001), 
especially the harvesting of hamstring grafts has been found to cause muscular weakness at 
high knee flexion angles (Makihara et al., 2006; Nakamura et al., 2002; Tashiro et al., 2003). 
Furthermore the availability of autogenous tendons is limited. In multi-ligamentous knee 
injuries the use of allografts is often required. Different allograft ligaments may be used: 
bone-patella-tendon-bone, hamstring, achilles or tibialis anterior/posterior tendons. 
However, no differences between the used allograft tissue have been reported, whereas 
significant differences exist, which sterilization processes were used (Carey et al. 2009; 
Krych et al. 2007). In a recent systematic review comparing ACL replacement using 
autografts with allografts, similar medium term results were reported in non-randomized 
studies (Carey et al., 2009). Still, immunogenic reactions may cause degenerative alterations 
and the potential risk of disease transmission remains. Using standard sterilization 
procedures like lyophilisation (Crawford et. al, 2004) or gamma irradiation (Fideler et al. 
1995; Gibbons et al. 1991) retroviruses (i.e. HIV) can hardly be destroyed.  
Apart from the ligaments, the meniscus plays a crucial role in the complex biomechanics of 
the knee, as it works as a shock absorber and transforms joint pressure in circular meniscus 
tension. This is mediated by the complex structure (mainly its circular collagen network) of 
the meniscus. Unfortunately its healing capacities are very poor. As soon as a radial tear 
destroys the circular collagen network or the horns are ruptured, the meniscus looses all 
biomechanical function. This leads to joint overload and might end in an overuse of the 
cartilage and an early onset of osteoarthritis (Lohmander et al. 2007; Allaire et al. 2008). 
Many improvements have been made to reconstruct the injured meniscus, but due to its 
biomechanical and anatomical specialities this is still impossible in many cases.  
The transplantation of meniscus allografts is a viable option but has its own problems as 
well (Packer et al. 2009). On the one hand there is the problem that there are too little donor 
organs as the meniscus of elderly people has usually degenerative alterations and can 
thereby not be used. Apart from the lack of organs it is difficult to get a suitable transplant 
fitting in size. In a recent work Van Thiel et al. 2009 could show that the fitting size of the 
meniscus is mainly correlated with height, weight and gender of the donor and recipient. 
Apart from that, the fixation is technically demanding. Because of this, the transplantation of 
meniscus is reserved to specialized centers. Unfortunately, long-term results still show 
problems due to immunogenic and degenerative alterations. Verdonk et al. (2006) examined 
the long- term results of meniscus transplantation clinically and radiologically and they 
could show, that the meniscus transplantation lead to an improvement of function and relief 
of pain. Nevertheless, substantial disability and knee pain were present at the follow up 
after 10 years. On MRI the meniscus transplants had signs of graft extrusion and an 
increased signal intensity indicating degeneration. The failure rate was 18% with conversion 
to a total arthroplasty (Verdonk 2006). Wirth et al. (2002) found  similar results but could 
show, that deep frozen meniscal grafts were superior compared to lyophilized meniscal 
grafts at a follow up of 3 and 14 years. The latter even showed similar results to the control 
group after meniscectomy. If those problems could be solved in the future, the meniscus 
transplantation might gain much popularity over time.  
As an alternative to allografts the use of synthetic tendon constructs (e.g. silk, Gore Tex, 
LAD) or meniscus prostheses (CMI, Actifit etc.) have emerged (Martinek 2006; van 
Tienen et. al 2009; Zaffagnini et al., 2008). Most of the prostheses used for ACL 
reconstruction have failed as they showed an adverse effect on the cartilage and caused in 
some cases a marked synovialitis. Though their biomechanical Properties were excellent 
initially, most of the prostheses had the problem of degradation, tunnel widening and high 
failure rates after several years (Muren et al., 2005; Roolker et al., 2000). Compared to the 
biomechanical properties of ligaments, meniscus tissue is even more complex and not 
surprising, the middle to long term results of the artificial meniscus constructs show 
different results from one study to the other, but in general do not reach the anatomic, 
biomechanical results (Buma et al., 2007). So far, artificial constructs (neither ACL nor 
meniscus) do not reach the biomechanical properties of autologous tissue and are therefore 
not an ideal long- term alternative.  
To improve the long-term outcome of ligament and meniscus allografts, new strategies are 
needed. Recently the use of extracellular matrix (ECM) scaffolds by means of 
acellularization of allograft tissue has become popular (Badylak et al., 2007, Badylak et al., 
2009). In the following we will depict the different means of acellularization, describe our 
used method and give future prospects in the field of tissue engineering concerning 
ligament and meniscus tissue. 
 
2. Acellularization methods 
Recently, biologic scaffold materials composed of extracellular matrix are widely used in 
surgical procedures for the reconstruction of numerous tissues and organs and their use in 
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orthopaedic research surgery has emerged over the last years. As scaffolds allograft or 
possibly xenograft tendons/meniscus are used, which are acellularized by different 
methods.  
 
The basic requirements for optimal acellularization methods are:  
1. removal of all cellular components as the cells (especially fibroblasts) and  
macrophages seem to play a crucial role in the cell- mediated immunogenic 
reactions, i.e. host versus graft reaction (Badylak 2008). 
 
2. preserving the extracellular matrix which is responsible for biomechanical 
stability and preserving chemoatractants and providing cell attachment sites for 
ingrowing cells (Reing 2009).  
 
The ECM has chemotactic factors that attract cells (Beattie et al., 2009) and supportive 
function for the diffusion of nutrients from the blood to the cells. Most important, the 
biomechanical properties are mediated by the extracellular matrix. For example, the tensile 
strength of tendons is mediated by its collagen I fibrils, whereas the hyaline cartilage 
properties are maintained by the interplay of a collagen II network with large proteoglycans 
(aggrecan) and negatively charged glycosaminoglycans (Tischer et al., 2002). Finally, the 
process of repopulation is dependent on an intact matrix and the used method should not be 
cytotoxic to allow cellular ingrowth. The repopulation can then happen in vitro before 
implantation or in vivo. 
Therefore different methods have been described for the acellularization of tissues and 
every method has its own advantages and disadvantages. Generally, two methods can be 
distuingished: first methods which destroy all cells, but leave cellular components and 
debris and second methods which remove all the cellular components from the tissue by 
chemical means. In the following section, the most common methods are now discussed in 
more detail. 
 
2.1. The Gamma irradiation 
The gamma irradiation is widely used and one of the methods with the longest experience. 
It is very effective in destroying cells and most of the pathogenic germs. Still the gamma 
irradiation faces a dilemma, as doses of 3.5 Mrad (35kGy) are needed to destroy the DNA of 
the HIV. However, using this amount of energy weakens the transplant, leading to loss of 
biomechanical stability, making it unsuitable for implantation (Fideler BM et al., 1995). In 
most cases irradiation doses of 1 to 2.5 Mrad (10- 25kGy) are used with a slight remaining 
risk of disease transmission (Buck et al., 1989). In a study by Curran it could be shown that 
irradiation of allografts with a dose of 20kGy lead to minor biomechanical properties 
compared to the untreated control group. Elongation was more than 27% higher and the 
load to failure was diminished as well (Curran et al., 2009). In a prospective randomized 
trial by Sun (Sun et al., 2009) the clinical outcome after ACL replacement with autograft 
patellar-tendon-bone and irradiated as well as non-irradiated allograft (all used allografts 
had been frozen) was examined. Whereas the non-irradiated allografts showed similar 
results to the autografts, the clinical outcome of the irradiated allografts was inferior in the 
clinical scores and the subjective instability was much more common in this group of 
patients. Taking that into account the irradiation can no longer be recommended as a 
sterilization procedure as it weakens the tissue and thereby negatively influences the 
biomechanical properties without reliably destroying retroviruses like HIV.  
 
2.2. Lyophilization/cryopreservation 
Lyophilization means the preparation of tissue by repetitive freezing and thawing. This 
leads to the destruction of cells, but as with irradiation the cellular components mainly 
remain within the extracellular matrix. The lyophiliation process has been widely used and 
has been proven as a simple and cheap method and is therefore most commonly used (Sass 
et al., 2009; Busam et. al, 2007; Lewis et al., 2008). Much work has been performed on the 
effects of cryopreservation on tendon allografts, but the potential adverse effects on 
mechanical properties and histological changes by ice crystal formation (Mahirogullari 
2007). In a work by Park 2008 the effects of cryopreservation or heating on the mechanical 
properties and histomorphology of rat bone-patellar tendon-bones (BTBs) were 
investigated. BTBs were processed by cryopreservation at -80°C for 3 weeks, or heating at 
+80°C for 10 min. Tensile testing and histomorphological examinations were performed. 
The cryopreservation of tendons showed less influences on their mechanical properties. 
When cryopreserved BTBs were fixed in frozen state by the freeze-substitution method, 
many widened interfibrillar spaces were observed. These results suggest that the collagen 
fibres of cryopreserved tendons were histomorphologically affected by ice crystals. The 
cryopreservation does not only affect the cellular components, but also the collagen matrix, 
which might have effects on the biomechanical properties as well.  
However, a new work by Gelber et al. (2009) showed that the ultra structure of the meniscus 
is not affected by cryopreservation. Therefore, an allograft stored in that way would not 
alter its biomechanical properties, although its cellular viability is highly unpredictable. As 
the immunogenicity is cell-mediated, this imponderability makes the cryopreservation not 
the method of choice for tissue engineering applications, especially as the fibril diameters in 
frozen menisci show a thinner diameter and had a higher degree of disarray. These 
alterations of the collagen network can partially explain the pathological changes found in 
shrunken menisci after transplantation (Gelber et al., 2008). 
 
2.3. High pressure treatment 
The treatment of tissue with hydrostatic high pressure has emerged over the last years. By 
this method tissue is exposed to hydrostatic high pressure of up to 600MPa for 10 minutes.  
Diehl et al. (2006) could show that this treatment had no adverse effect on the biomechanical 
properties of the treated tissue. The cells were destroyed by this treatment and similar to the 
lyophilization the cellular components remain in the extracellular matrix and might thereby 
still be immunogenic. Apart from the use in tissues, high hydrostatic pressure (HHP) is 
widely used in the food processing industry, for example to inactivate vegetative 
microorganisms in meat products, milk and juice, thereby avoiding the addition of any 
chemical preservatives. Besides this HHP is also an attractive novel approach to effectively 
kill tumor cells in bone, cartilage or tendon ex vivo while leaving the tissues' mechanical 
properties unimpaired, thus allowing possible reimplantation of the resected tissue explants 
(Diehl et al., 2006, Diehl et al., 2008). However, human studies on this topic are still missing. 
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2.4. Enzymatic treatment 
Acellularization using enzymatic treatment uses various enzymes like trypsin, collagenase 
and others to open up the ECM and remove cellular components. For example Maier et al. 
described an enzymatic way of acellularization of ovine meniscus tissue (Maier et al. 2007). 
Forty-one menisci were used to establish their own protocol. They used distilled water, 
trypsin and collagenase A to acellularize meniscus samples and could show that the 
biomechanical and the biochemical properties were left almost unaffected. In a recently 
published work by Vavken et al. 2009, they could demonstrate the effectiveness of 
enzymatic acellularization of the ACL. Therefore, they used a combination of Trypsin, 
EDTA and PBS and could show that the samples could be acellularized by this enzymatic 
treatment. The glycosaminoglycan content was negatively affected as well.  
Taking everything into account, we believe that  enzymatic treatment and especially the 
combination of collagenase and trypsin has adverse effects on the extracellular  matrix and 
the collagen network. These enzymes can actually destroy the ECM and this could cause 
problems in reseeding the acellularized samples or even the biomechanical results. Future 
research would be needed to prove the safety of these methods.  
 
2.5. Chemical acellularisation by solvents/detergents 
A newer promising approach is the extraction of cells by chemical solvents/detergents. The 
most widely used chemicals are sodium dodecyl sulphate (SDS, an ionic detergent), Triton-
X (a non-ionic detergent) and tri-nitro-butyl phosphate (TnBP). They have been described to 
acellularize tissue and successful application was performed on small intestine (Badylak et 
al., 1995), the urinary bladder (Chen et al.,  1999), the liver (Brown et al., 2006), arterial 
vasculature (Walles et al.,  2003), dermis (Armour et al., 2006), heart valves (Cebotari et al., 
2006) and oesophagus transplants (Bhrany et al. 2006; Gilbert et al., 2006) among others. In 
orthopaedic surgery there have been experiments using Graft jacket®  in irreparable rotator 
cuff defects for tendon augmentation (Barber et al., 2006; Coons et al., 2006). Acellularization 
of tendons (Tischer et al., 2007; Gilbert et al., 2006) and meniscal samples (Sandmann et al. 
2008; Stapleton et al., 2008) has caused further interest in this technique. 
Bolland et al. aimed to produce a natural, acellular matrix from porcine bladder tissue for 
use as a scaffold in developing a tissue-engineered bladder replacement. They used full-
thickness, intact porcine bladders, which were acellularised by distention and immersion in 
hypotonic buffer containing 0.1% (w/v) SDS and nuclease enzymes. Histological analysis of 
the resultant matrices showed that they were completely acellular whereas the major 
structural proteins had been retained. Intracellularly, some poorly soluble proteins 
remained. The amount of DNA per mg dry weight of fresh porcine bladder was 2.8 (+/-0.1) 
g/mg compared to 0.1 (+/-0.1) g/mg in acellularised bladder. In biomechanical testing 
the tensile testing indicated that acellularisation did not significantly compromise the tensile 
strength of the tissue. Cytotoxicity assays using porcine smooth muscle cell cultures 
excluded the presence of soluble toxins in the biomaterial (Bolland et al., 2007). A newer 
work by Gilbert et al. has shown that the presence of remaining intracellular DNA might not 
have as adverse effects as at first suspected. They examined the DNA content of 
commercially available ECM scaffold materials and compared their DNA content with 
scaffolds prepared in the laboratory using different acellularisation protocols. Most of the 
examined scaffolds still contained some amounts of DNA (4 out of 6 from the commercially 
available scaffolds and 2 out of 3 from the produced ECM scaffolds). Interestingly, scaffolds 
which retained higher amounts of DNA did not show worse results than the scaffolds with 
less DNA (Gilbert et al., 2008). In a work by Brown et al., it could be shown in an animal 
model that the presence of cellular components within the extracellular matrix scaffold 
modulates the phenotype of the macrophages participating in the host response following 
implantation. Scaffolds containing cellular components (even autologous cellular 
components), elicited a predominantly M1 type macrophage response, resulting in a more 
dense connective tissue and/or scarring. Acellular scaffolds, however, were observed to 
elicit a predominantly M2 type macrophage response, which results in a more constructive 
type of remodelling response (Brown et al., 2009). 
In the same animal model (abdominal wall defect in rats covered with several ECM 
scaffolds, i.e. porcine small intestinal submucosa (SIS), noncrosslinked SIS, and autologous 
body wall ) the effect of macrophages that derive from peripheral blood in the degradation 
of ECM scaffolds was examined and Valentine et al. could show, that peripheral blood 
monocytes are required for the early and rapid degradation of both SIS scaffolds and 
autologous body wall, and that carbodiimide crosslinked SIS’s are resistant to macrophage-
mediated degradation (Valentin et al., 2009). Apart from the macrophages the T 
lymphocytes play a crucial role in organ rejection, especially in cell-mediated immune 
responses to xenografts (Strom et al., 1996). Th1 lymphocytes produce cytokines such as 
interleukin (IL)-2, interferon (IFN)-, and tumor necrosis factor (TNF)-, leading to 
macrophage activation, stimulation of complement and differentiation of CD8+ cells to a 
cytotoxic phenotype, which leads to transplant rejection (Chen et al., 1996). In contrast, Th2 
lymphocytes produce IL-4, IL-5, IL-6, and IL-10, cytokines that do not activate macrophages. 
Resulting from this, the activation of the Th2 pathway is associated with transplant 
acceptance (Chen et al., 1995). The only ECM scaffold material for which the Th1/Th2 
response has been characterized so far is small intestine ECM (Allman et al., 2001). Allman 
implanted SIS-ECM subcutaneously in mice and could show that the expression of IL-4 
(Th2) was increased, while the expression of IFN- (Th1) was markedly decreased by 100-
fold compared to the response elicited by the xenogeneic muscle group. Although there was 
an immune response to the SIS-ECM after implantation, this response was dominated by the 
Th2 pathway mediators, lacking an acute rejection.  
Since similar studies have not been conducted for other forms of ECM scaffold materials, it 
is not possible to determine whether they would elicit the same type of host response. 
Thinking of the diversity of different tissues and scaffolds, it seems likely that the host 
response to biologic scaffolds will vary to a large degree following implantation. Further 
research is needed to understand the immunogenic reactions to the implanted scaffolds and 
the effects of acellularisation on the repopulation of these scaffolds. One step in this 
direction are two recent publications by Beattie et al. and Reing et al. who could show that 
the acellularisation process and the produced degradation products are important 
modulators for the recruitment and proliferation of appropriate cell types during the 
remodelling process (Beattie et al., 2009; Reing et al., 2009).  
The first study using acellularized tissue in orthopaedic research was performed by 
Cartmell et al. (Cartmell et al., 2000). Therein, they investigated the effectiveness of 
treatment of rat tail tendons with SDS, Tri (n-butyl) phosphate and Triton-X and found that 
both the treatment with SDS (1% for 24h) or TnBP (1%for 48h) resulted in an acellular matrix 
with retention of almost normal histological structure. The biomechanical properties were 
similar to native tendons. In contrast, Triton-X (1% for 24h) disrupted the collagen fibers and 
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2.4. Enzymatic treatment 
Acellularization using enzymatic treatment uses various enzymes like trypsin, collagenase 
and others to open up the ECM and remove cellular components. For example Maier et al. 
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biomechanical and the biochemical properties were left almost unaffected. In a recently 
published work by Vavken et al. 2009, they could demonstrate the effectiveness of 
enzymatic acellularization of the ACL. Therefore, they used a combination of Trypsin, 
EDTA and PBS and could show that the samples could be acellularized by this enzymatic 
treatment. The glycosaminoglycan content was negatively affected as well.  
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research would be needed to prove the safety of these methods.  
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macrophage activation, stimulation of complement and differentiation of CD8+ cells to a 
cytotoxic phenotype, which leads to transplant rejection (Chen et al., 1996). In contrast, Th2 
lymphocytes produce IL-4, IL-5, IL-6, and IL-10, cytokines that do not activate macrophages. 
Resulting from this, the activation of the Th2 pathway is associated with transplant 
acceptance (Chen et al., 1995). The only ECM scaffold material for which the Th1/Th2 
response has been characterized so far is small intestine ECM (Allman et al., 2001). Allman 
implanted SIS-ECM subcutaneously in mice and could show that the expression of IL-4 
(Th2) was increased, while the expression of IFN- (Th1) was markedly decreased by 100-
fold compared to the response elicited by the xenogeneic muscle group. Although there was 
an immune response to the SIS-ECM after implantation, this response was dominated by the 
Th2 pathway mediators, lacking an acute rejection.  
Since similar studies have not been conducted for other forms of ECM scaffold materials, it 
is not possible to determine whether they would elicit the same type of host response. 
Thinking of the diversity of different tissues and scaffolds, it seems likely that the host 
response to biologic scaffolds will vary to a large degree following implantation. Further 
research is needed to understand the immunogenic reactions to the implanted scaffolds and 
the effects of acellularisation on the repopulation of these scaffolds. One step in this 
direction are two recent publications by Beattie et al. and Reing et al. who could show that 
the acellularisation process and the produced degradation products are important 
modulators for the recruitment and proliferation of appropriate cell types during the 
remodelling process (Beattie et al., 2009; Reing et al., 2009).  
The first study using acellularized tissue in orthopaedic research was performed by 
Cartmell et al. (Cartmell et al., 2000). Therein, they investigated the effectiveness of 
treatment of rat tail tendons with SDS, Tri (n-butyl) phosphate and Triton-X and found that 
both the treatment with SDS (1% for 24h) or TnBP (1%for 48h) resulted in an acellular matrix 
with retention of almost normal histological structure. The biomechanical properties were 
similar to native tendons. In contrast, Triton-X (1% for 24h) disrupted the collagen fibers and 
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was not as effective in acellularization as the two other methods, causing a disruption of the 
normal D-period of reconstituted rat tail tendon collagen fibers and an approximate 50% 
decrease in wet tensile strength and stiffness values. Following this, in 2004 Cartmell and 
Dunn could show that bone-patella-tendon-bone ligaments from rabbits could be 
successfully acellularized and reseeded with fibroblasts. Fibroblast proliferation rate was 
thereby slightly retarded on SDS- treated patellar tendons, whereas the repopulation in the 
TnBP- treated group was successful. Ingram et al. examined the additional effects of 
ultrasound on the repopulation process of natural tendon scaffolds acellularized with 0.1% 
SDS and found that repopulation with tenocytes was improved (Ingram et al., 2007). The 
work of Woods et al. compared the effectiveness of three extraction protocols in the 
development of an acellularized porcine bone-anterior cruciate ligament- bone graft (Woods 
et al. 2005). Therefore, they combined Triton-X (1% for 24 hours) either with SDS (1% for 24 
hours) or TnBP (1% for 24 hours). The combination of Triton-X with SDS was most effective 
at removing cell nuclei and intracellular protein (vimentin) from the ACL but affected both 
the collagen and glycosaminoglycan (GAG) components of the extracellular matrix while 
increasing the tensile stiffness of the ligament. In contrast, the combination of Triton-X with 
Triton-X was least effective of the three treatments in terms of cellular extraction, anyway its 
use did not alter the mechanical (stiffness and failure load) and biochemical (collagen and 
GAG content) properties of the ACL compared to the control group significantly. Triton-
TnBP matched the level of decellularization achieved by Triton-SDS in terms of visible cell 
nuclei. It had lower effects on the extraction of the intracellular vimentin. Though Triton-
TnBP did change the collagen content of the ACL (significant reduction of collagen content), 
the mechanical properties (tensile stiffness, failure load) were left unaffected. Overall, all 
three decellularization treatments maintained adequate mechanical and biochemical 
properties of B-ACL-B grafts. In a study by Vavken et al. 2009 the effectiveness of the 
acellularization of porcine ACL with Triton-X (0.25% for 24 hours), SDS (0.1% for 24 hours) 
and trypsin (0.1% for 24 hours) was examined. All acellularization protocols reduced DNA 
content, with triton-X treatment having the greatest effect. Concurrently, acellularization did 
not affect tissue collagen or total protein content, but did decrease glycosaminoglycan 
content. In this work Triton-X had the lowest effect on glycosaminoglycan depletion, so that 
the author favoured the acellularization with Triton-X. These different results show that 
future research is needed to find the most effective and most gentle way of acellularization 
to prepare the scaffold for repopulation. 
For the acellularization of meniscal samples there is even more research needed. We could 
show (Sandmann et al., 2009) that the treatment of human meniscal samples with SDS 2% 
for 2 weeks is highly effective in acellularization (see chapter 5). In another work published 
by Stapleton et al. 2008 a different protocol was used for the acellularization of porcine 
meniscal samples. The menisci were acellularized by exposing the tissue to repetitive freeze-
thaw cycles, incubation in hypotonic tris buffer, 0.1% (w/v) sodium dodecyl sulfate in 
hypotonic buffer plus protease inhibitors, nucleases and hypertonic buffer followed by 
desinfection using 0.1% (v/v) peracetic acid and final washing in phosphate-buffered saline. 
Histological, immunohistochemical, and biochemical analyses of the acellularized tissue 
confirmed the retention of the major structural proteins. However, a 59.4% loss of 
glycosaminoglycan content was noticed but with no significant alteration of the 
biomechanical characteristics. Furthermore, acellularized tissue and extracts were not 
cytotoxic to cells.  
Up to now, there are many unanswered questions regarding acelluarized scaffolds. The 
method of acellularization seems to be very promising of creating a collagen scaffold for 
tissue engineering of ligaments and meniscus, as the extracellular matrix and thereby the 
biomechanical properties are mainly preserved. However, in vivo animal studies are still 
missing. In the future acellularized tendons or meniscus samples might play a crucial role in 
orthopaedic surgery as do several extracellular matrix materials, which have been 
commercialized so far and are applied in a variety of indications reaching from the 
reconstruction of soft tissue defects (Ueno et al., 2004) to grafts in vascular surgery (Hiles et 
al., 1993) or neurosurgery (LeVisage et al., 2005).  
 
3. Repopulation of acellularized scaffolds 
The repopulation of acellularized tissue using detergents/solvents might improve and 
fasten incorporation and remodelling processes and thereby improve the long- term results. 
Cell proliferation on acellularized tissue is dependent on the used chemical treatment, with 
SDS showing the best acellularization rate but slightly diminished cell proliferation 
compared to Triton-X or TnbP (Gratzer et al., 2006, also see previous section). 
In a study published by Cartmell in 2004 the seeding of acellularized tendons was most 
effective in TnBP treated tendons. They were seeded with fibroblasts and viable tissue-
engineered grafts could be created. These modified allografts could be developed into 
mechanically functional delivery vehicles for cells, gene therapy vectors, or other biological 
agents. Whereas multiple in vitro studies have been performed to repopulate acellular tissue 
(Cartmell et al., 2004; Gratzer et al., 2006), in vivo animal studies are sparse. In a study by 
Vavken et al. 2009 it could be shown that acellularized tendons treated with Triton-X could 
best be repopulated as the extracellular matrix was mainly unaffected. SDS treated tissue 
seems more difficult to repopulate, whereas it shows the best acellularization properties. 
Harrison et al., 2005 compared the effect of different culture condition variables (i.e. (1) the 
number of cells used for seeding, (2) the addition of epidermal growth factor (EGF), and (3) 
culture duration) on the repopulation of porcine ACL with fibroblasts. They found that 
Triton-X and TnBP acellularized ACL’s were suitable for repopulation. Cellular ingrowth in 
the SDS group was successful, but less effective. At first it was supposed that this might be 
due to cytotoxic effects of SDS, but Gratzer et al., 2006 showed that not the cytotoxicity but 
probably matrix alterations were responsible for that.  
Nevertheless, little is known about the optimal cell source for tissue engineering of 
ligaments. Van Eijk et al. 2004 searched for the optimal cell source for tissue engineering of 
the anterior cruciate ligament. They compared the use of bone marrow stromal cells 
(BMSCs), ACL fibroblasts and skin fibroblasts and seeded them onto a resorbable suture 
material [poly(L-lactide/glycolide) multifilaments] at five different seeding densities, and 
cultured them for up to 12 days. All cell types tested attached to the suture material, 
proliferated, and synthesized extracellular matrix rich in collagen type I. On day 12 the 
scaffolds seeded with BMSCs showed the highest DNA content (p < 0.01) and the highest 
collagen production (p < 0.05 for the two highest seeding densities). Scaffolds seeded with 
ACL fibroblasts showed the lowest DNA content and collagen production. Another 
interesting study examined the proliferation and survival of different cell types (ACL 
fibroblasts vs. skin fibroblasts) on ligament analogues in the harsh environment of the rabbit 
knee joint (Belincampini 1998). Liu et al 2008 concluded in their study, that BMSC are a 
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probably matrix alterations were responsible for that.  
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cultured them for up to 12 days. All cell types tested attached to the suture material, 
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better cell source than ACL fibroblasts when using silk scaffolds for ACL tissue engineering. 
The same conclusion was reached in the study be Ge et al. in 2005. 
 
4. Tissue engineering of the ACL - own work 
The aim of our study (Tischer et al. 2007) was to investigate investigate whether the treatment 
of rabbit  semitendinosus tendons with SDS leads to cell free constructs and whether these 
could serve as a scaffold for tissue engineering of the ACL.  Therefore allograft semitendinosus 
tendons were treated with SDS using a special protocol (see table 1).  
 
Day 1 Deionized water 24h 
Day 2 1% SDS 24h 
Day 3 Deionized water 24h 
Day 4 70% ethanol 24h 
Day 5 Phosphate buffered saline (PBS) Several times 
Table 1. Acellularization protocol for rabbit semitendinosus tendons 
 
Following the acellularization process, the tendons were seeded with autologous dermal 
fibroblasts. Therefore dermal fibroblasts were taken from a small skin biopsy, extracted and 
cultured for approximately 10 days until the cells were confluent. The cells were split and 
after confluence solutions were made with a cell number of 1.0x106 cells/ 0.5ml medium. 
This suspension was injected into the acellular tendons in line with the collagen fibres. 
Additionally, cell suspension was applied for 4 days to the tendon surface for outer 
settlement of the cells. 
Following, the tendons were tested biomechanically and histologically. For biomechanical 
testing three groups were examined, being nine native tendons, nine acellular tendons and 
nine tendons seeded with autologous dermal fibroblasts for 4 days of culture. The load to 
failure test was performed on a universal material test machine (Modell Zwicki 1120, Fa. 
Zwick, Germany) with a preload of 2N. The load- to failure test was performed by 
increasing the tensile loading continuously with a speed of 10mm/min. Apart from the load 
to failure the biomechanical properties elongation of tendon until rupture and the stiffness 
were recorded.  
For histological examination six tendons were used in each group. As standard all 
longitudinal sections were stained with hematoxylin-eosin. For analysis of changes in the 
extracellular matrix, tendons from each group were stained with a panel of monoclonal 
antibodies directed against collagen 1, 3, 4, 6, Pro-collagen 1, versican and vimentin. 
Histological staining with a standard Hematoxylin/Eosin staining revealed that all cells 
could be removed from the tendons and the constructs were cell-free (see figure 1). No more 
cell nuclei could be seen. The acellularization process lead to more interfascicular spaces in 
the SDS group. The group with the seeded tendon constructs lead to increased irregularities 
in the tendons. The cells were viable, but most of them did not show the typical spindle 
shape appearance. Survival of the cells was proven by immunohistochemical staining for 
pro-collagen I, the precursor molecule of collagen I, which was absent after acellularization 
but was found around the seeded cells after seeding.  
 Fig. 1. Histological appearance of native (a) and acellular (b) rabbit semitendinosus tendon. 
No more cell nuclei can be found after acellularization (b). (HE staining, 100x 
magnification). 
 
The treatment of the tendon constructs did not show any staining irregularities in the 
composition of the extracellular matrix. Staining for the collagens I, III, IV and VI did not 
show significant differences between the groups.  Furthermore the distribution of 
macromolecules like versican was equally distributed in all three tested groups. Vimentin, 
an intermediary filament especially characteristic for fibroblasts was decreased, but clearly 
detectable. 
 
Biomechanical results 
For biomechanical testing nine native tendons, nine acellular tendons and nine cells seeded 
for 4 days were tested. The tests were done using a universal material test machine and with 
load- to failure testing. The maximum load to failure, the elongation of the tendon until 
rupture and the stiffness could be recorded (see table 2). The load to failure between the 
three groups was statistically not significant as is shown in the following table. 
 Load to failure Stiffness Elongation 
Native tendons 134.5  12.9N 58.9  6.57N/mm 2.47  0.33% 
Acellular tendons 118.5  7.3N 48.5  3.05N/mm 2.46  0.06% 
Seeded tendons 132.3  5.6N 18.5  1.73N/mm 7.50  0.5% 
 
Table 2. Results of load to failure testing of rabbit semitendinosus tendons 
 
The elongation of the seeded tendons as well as the stiffness were significantly elevated 
compared to the acellular or the native control group. The most evident explanation might 
be that the seeded tendons underwent a swelling process during cell culture, which was not 
compensated for by our only short pretensioning before testing. However, for comparability 
between the other groups, pretensioning was not changed.  
 
Animal model 
While the in vitro results of repopulated acellular scaffold were very promising, in vivo 
results are missing. Therefore the above described scaffold was tested in an in vivo rabbit 
model of ACL replacement (see figure 2). Therein we could show that SDS acellularized, 
allogenic constructs colonized with autologous fibroblasts (Tischer et al. 2009) had 
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better cell source than ACL fibroblasts when using silk scaffolds for ACL tissue engineering. 
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Table 1. Acellularization protocol for rabbit semitendinosus tendons 
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 Fig. 1. Histological appearance of native (a) and acellular (b) rabbit semitendinosus tendon. 
No more cell nuclei can be found after acellularization (b). (HE staining, 100x 
magnification). 
 
The treatment of the tendon constructs did not show any staining irregularities in the 
composition of the extracellular matrix. Staining for the collagens I, III, IV and VI did not 
show significant differences between the groups.  Furthermore the distribution of 
macromolecules like versican was equally distributed in all three tested groups. Vimentin, 
an intermediary filament especially characteristic for fibroblasts was decreased, but clearly 
detectable. 
 
Biomechanical results 
For biomechanical testing nine native tendons, nine acellular tendons and nine cells seeded 
for 4 days were tested. The tests were done using a universal material test machine and with 
load- to failure testing. The maximum load to failure, the elongation of the tendon until 
rupture and the stiffness could be recorded (see table 2). The load to failure between the 
three groups was statistically not significant as is shown in the following table. 
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Seeded tendons 132.3  5.6N 18.5  1.73N/mm 7.50  0.5% 
 
Table 2. Results of load to failure testing of rabbit semitendinosus tendons 
 
The elongation of the seeded tendons as well as the stiffness were significantly elevated 
compared to the acellular or the native control group. The most evident explanation might 
be that the seeded tendons underwent a swelling process during cell culture, which was not 
compensated for by our only short pretensioning before testing. However, for comparability 
between the other groups, pretensioning was not changed.  
 
Animal model 
While the in vitro results of repopulated acellular scaffold were very promising, in vivo 
results are missing. Therefore the above described scaffold was tested in an in vivo rabbit 
model of ACL replacement (see figure 2). Therein we could show that SDS acellularized, 
allogenic constructs colonized with autologous fibroblasts (Tischer et al. 2009) had 
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significantly weaker biomechanical properties than autologous tendons. In histological 
examination inflammatory reactions and acellular regions could be noticed, which might be 
due to the used acellularization method. However, since this is the first study in the field, 
more research as to be performed. 
 
 Fig. 2. Rabbit ACL replacement model using double stranded semitendinosus tendon at 
anatomical insertion site. Fixation was performed using custom made endobuttons. 
 
A lot of ACL research has been done in the rabbit model and though it is a good animal 
model, future research in the field of double bundle research should take place in bigger 
animals, as their anatomy and the forces come closer to the forces in human knee joints. 
Questions, like the best fixation technique or the advantages of the double bundle 
reconstruction should be best addressed in bigger animals (Tischer et al., 2009). 
 
Discussion 
Solvents, like SDS or Triton- X have been shown to be effective agents in acellularizing 
tissues. In our work we focussed on SDS and our results show that with the solvent SDS it is 
possible to acellularize tendon tissue. The advantage compared to other methods is that by 
the acellularization with SDS the constructs are made cell- free and all the cell- detritus is 
washed out as well. This makes them less immunogenic as the cell-based reactions do not 
take place in the same way. The acellularization with SDS has been shown to be most 
effective.  
Secondly, SDS acellularized constructs can be reseeded again. This might be a little more 
difficult than when using other methods due to an alteration of extracellular matrix 
hindering repopulation (Gratzer et al., 2006), but it has been shown to work (Ingram et al., 
2007). Acellular and repopulated scaffolds might be very useful in the future as the 
integration of transplants can thereby be improved. A small dermal biopsy followed by cell 
culture might be enough to create a “custom-fit” transplant. Future research has to be done 
in this field to evaluate the possibilities. 
 
5. Tissue engineering of the Meniscus - own work 
Tissue engineering of the meniscus is even more complex than that of ligaments or tendons, 
as the meniscus has an even more complex collagen network and most of the methods 
described before have lead to a failure in acellularization or a deterioration of the 
biomechanical properties. Inspired by the work mentioned above, we tried to apply the 
same acellularization protocol and initially failed. After gradually improving the SDS 
concentration and time we finally succeeded in acellularization using SDS for meniscus 
samples (see table 3). Since the diffusion of chemicals is time dependent, larger tissue 
specimens are expected to take longer before acellularization is achieved. A higher 
concentration of SDS (2% compared to 1%) and a longer duration were needed to get a cell- 
free meniscus construct. 
 
Day 1 Deionized water 24h 
Day 2- 14 2% SDS  
Day 15 Deionized water 24h 
Day 16 70% ethanol 24h 
Day 17 Phosphate buffered saline (PBS) Several times 
Table 3. Extraction protocol for human meniscus constructs 
 
Histological and immunhistochemical results 
After treatment with SDS 2% for 2 weeks all meniscus samples (both medial and lateral) 
were identified as acellular by hematoxylin/eosin staining. Phase-contrast examinations 
revealed regular collagen bundle arrangement in the acellular specimens as seen in intact 
menisci. Immunohistochemically, no differences in the labelling patterns for collagen 1, 2 
and 6 were observed when compared with intact menisci. Whereas for collagen I there was 
strong labelling in the whole meniscus, collagen 2 was labelled only in the fibrocartilaginous 
section of both groups. Collagen VI staining was evenly distributed throughout the 
meniscus tissue, both in acellularized and intact menisci. 
 
 Fig. 3. Native (a) and acellular (b) meniscus samples at 200x magnification. 
 
Biomechanical results 
After the acellularization process a total of 5 medial and 5 lateral human menisci were 
examined using a ball indention test. The undersurface of the menisci was oriented 
perpendicular to the testing device. Three cylinders with a diameter of 5.0 mm and a height 
of 4.0 mm were punched out of each meniscus. These cylinders were put into a custom-
made device and the upper part of the cylinder was shaped to create a surface parallel to the 
base. The sample was then put into a custom-designed metallic plate with a circular cavity 
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significantly weaker biomechanical properties than autologous tendons. In histological 
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take place in the same way. The acellularization with SDS has been shown to be most 
effective.  
Secondly, SDS acellularized constructs can be reseeded again. This might be a little more 
difficult than when using other methods due to an alteration of extracellular matrix 
hindering repopulation (Gratzer et al., 2006), but it has been shown to work (Ingram et al., 
2007). Acellular and repopulated scaffolds might be very useful in the future as the 
integration of transplants can thereby be improved. A small dermal biopsy followed by cell 
culture might be enough to create a “custom-fit” transplant. Future research has to be done 
in this field to evaluate the possibilities. 
 
5. Tissue engineering of the Meniscus - own work 
Tissue engineering of the meniscus is even more complex than that of ligaments or tendons, 
as the meniscus has an even more complex collagen network and most of the methods 
described before have lead to a failure in acellularization or a deterioration of the 
biomechanical properties. Inspired by the work mentioned above, we tried to apply the 
same acellularization protocol and initially failed. After gradually improving the SDS 
concentration and time we finally succeeded in acellularization using SDS for meniscus 
samples (see table 3). Since the diffusion of chemicals is time dependent, larger tissue 
specimens are expected to take longer before acellularization is achieved. A higher 
concentration of SDS (2% compared to 1%) and a longer duration were needed to get a cell- 
free meniscus construct. 
 
Day 1 Deionized water 24h 
Day 2- 14 2% SDS  
Day 15 Deionized water 24h 
Day 16 70% ethanol 24h 
Day 17 Phosphate buffered saline (PBS) Several times 
Table 3. Extraction protocol for human meniscus constructs 
 
Histological and immunhistochemical results 
After treatment with SDS 2% for 2 weeks all meniscus samples (both medial and lateral) 
were identified as acellular by hematoxylin/eosin staining. Phase-contrast examinations 
revealed regular collagen bundle arrangement in the acellular specimens as seen in intact 
menisci. Immunohistochemically, no differences in the labelling patterns for collagen 1, 2 
and 6 were observed when compared with intact menisci. Whereas for collagen I there was 
strong labelling in the whole meniscus, collagen 2 was labelled only in the fibrocartilaginous 
section of both groups. Collagen VI staining was evenly distributed throughout the 
meniscus tissue, both in acellularized and intact menisci. 
 
 Fig. 3. Native (a) and acellular (b) meniscus samples at 200x magnification. 
 
Biomechanical results 
After the acellularization process a total of 5 medial and 5 lateral human menisci were 
examined using a ball indention test. The undersurface of the menisci was oriented 
perpendicular to the testing device. Three cylinders with a diameter of 5.0 mm and a height 
of 4.0 mm were punched out of each meniscus. These cylinders were put into a custom-
made device and the upper part of the cylinder was shaped to create a surface parallel to the 
base. The sample was then put into a custom-designed metallic plate with a circular cavity 
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(diameter 5.0 mm and depth 4.0 mm) to prevent the samples from dislocating during testing 
(see figure 4). The test was performed as a minimally constraint compression-relaxation test. 
During testing, the meniscus samples were kept moist using physiologic saline solution. A 
preload of 0.1 N was used and samples were checked intermittently during testing for 
displacement. The test cycle consisted of four phases: preloading of the sample with 0.1 N; 
dynamic compression with a constant load velocity of 5 mm/min until 7 N; static 
compression of the sample for 60 s with a load of 7 N; relaxation of the sample with a 
constant unload velocity of 1 mm/min until a load of 0.15 N. After an interval of 60 s, the 
new test cycle started until a total number of five test cycles were reached. Load, indentor 
position, and time were displayed by the test software TestXpert and the following three 
biomechanical values could be calculated: (1) Relative sample compression calculated by the 
indentor position in relation to absolute sample height at the end of the dynamic 
compression phase (Compression is an indicator for viscosity and characterizes the ability of 
the tested tissue to evade the indenter) (2) ) Stiffness determined from the linear elastic slope 
of the loading curve between 2 and 5 N. High stiffness values mean high elasticity and vice 
versa. (3) Residual force (load measured at the end of the static compression phase). The 
residual force is influenced by the ability of tissue to evade the indenter in unconstraint 
compression (viscosity) as well as by the reset forces present in the tested tissue (elasticity). 
High residual forces show more elastic than viscous properties.  
 
 Fig. 4. Scheme of the ball indention trial (Sandmann et al., 2009). 
 
The testing showed that the acellularization did not affect the biomechanical properties of 
the tested tissue. The test was performed with cyclic loading in 5 cycles with a maximum 
load of 7N. Between the cycles 60seconds of relaxation were used. Stiffness increased 
significantly throughout testing by 162% (native meniscus) and 143% (acellular meniscus). 
During each testing cycle the differences between the two groups—intact meniscus and 
acellular scaffold—were not statistically significant. Mean compression of sample height 
was 32% (±7.2%) for intact meniscus samples after the fifth cycle compared to 35% (±8.3%) 
in the scaffolds. Scaffold compression exceeded compression of intact meniscus by 9%, 
being not statistically significant (p > 0.05). The residual force of the two groups increased 
after each cycle, but no statistically significant difference could be noticed. Biomechanical 
results were not significantly different comparing processed medial or processed lateral 
meniscus samples with the control group.  
 
 Stiffness 
(cycle 1) 
Stiffness 
(cycle 5) 
Mean 
compression 
height after 5 
cycles 
Residual force 
(cycle 1) 
Resiudal 
force 
(cycle 5) 
Native 
meniscus 
11.6 ± 3.2 
N/mm   
31.1 ± 3.3 
N/mm 
32% (±7.2%) 1.0 ± 0.41 N 3.0± 0.36 
N 
Acellular 
meniscus 
12.3 ± 2.9 
N/mm 
30 ± 3.2 
N/mm 
35% (±8.3%) 3.1 ± 0.4 N 3.2 ± 0.41 
N 
Table 4. Results of biomechanical testing 
 
Discussion 
Comparable to the tissue engineering of tendons the treatment of human meniscus samples 
with the potent solvent SDS generated cell-free meniscus scaffolds. Theses scaffolds have 
been shown to be biomechanically stable with characteristics similar to native meniscus 
samples. Special caution was given to the different biomechanical characteristics of 
meniscus tissue compared to tendon tissue. Seeding of the acellularized menisci has not 
been tested so far but future research might have to answer the question, whether 
repopulation of meniscus samples is possible and whether the repopulation rates can be 
improved by different stimulation methods like mechanical stimuli generated in bioreactors. 
 
6. Outlook 
The ACL and the meniscus are the both structures in the knee joint which are frequently 
injured and so far in most cases no restoration of the original anatomy is possible. Especially 
the development of osteoarthrosis in the long term is still an unsolved problem. Fortunately, 
many advances have been made in the surgical reconstruction of the ACL and the 
disastrous total meniscectomy has been abandoned long ago. The role of new surgical 
techniques like double bundle ACL surgery still has to be found. 
Apart from the acellularization of tissues, the use of growth factors, additionally or alone, 
seems to be a very promising option in improving the long- term results. Especially in 
meniscus transplants those factors that stimulate matrix synthesis and inhibit degradation of 
the extracellular matrix could be very useful. Future research has to point on the 
repopulation process and its improvement.  Angiogenic growth factors might contribute to 
even further improve the results. Maybe the use of bioreactors producing adequate 
mechanical stimuli, growth factors or synthetic scaffolds (e.g. silk) will help to solve the 
remaining questions.  
 
www.intechopen.com
Tissue engineering of the anterior cruciate ligament and meniscus using acellularized scaffolds 451
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versa. (3) Residual force (load measured at the end of the static compression phase). The 
residual force is influenced by the ability of tissue to evade the indenter in unconstraint 
compression (viscosity) as well as by the reset forces present in the tested tissue (elasticity). 
High residual forces show more elastic than viscous properties.  
 
 Fig. 4. Scheme of the ball indention trial (Sandmann et al., 2009). 
 
The testing showed that the acellularization did not affect the biomechanical properties of 
the tested tissue. The test was performed with cyclic loading in 5 cycles with a maximum 
load of 7N. Between the cycles 60seconds of relaxation were used. Stiffness increased 
significantly throughout testing by 162% (native meniscus) and 143% (acellular meniscus). 
During each testing cycle the differences between the two groups—intact meniscus and 
acellular scaffold—were not statistically significant. Mean compression of sample height 
was 32% (±7.2%) for intact meniscus samples after the fifth cycle compared to 35% (±8.3%) 
in the scaffolds. Scaffold compression exceeded compression of intact meniscus by 9%, 
being not statistically significant (p > 0.05). The residual force of the two groups increased 
after each cycle, but no statistically significant difference could be noticed. Biomechanical 
results were not significantly different comparing processed medial or processed lateral 
meniscus samples with the control group.  
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Comparable to the tissue engineering of tendons the treatment of human meniscus samples 
with the potent solvent SDS generated cell-free meniscus scaffolds. Theses scaffolds have 
been shown to be biomechanically stable with characteristics similar to native meniscus 
samples. Special caution was given to the different biomechanical characteristics of 
meniscus tissue compared to tendon tissue. Seeding of the acellularized menisci has not 
been tested so far but future research might have to answer the question, whether 
repopulation of meniscus samples is possible and whether the repopulation rates can be 
improved by different stimulation methods like mechanical stimuli generated in bioreactors. 
 
6. Outlook 
The ACL and the meniscus are the both structures in the knee joint which are frequently 
injured and so far in most cases no restoration of the original anatomy is possible. Especially 
the development of osteoarthrosis in the long term is still an unsolved problem. Fortunately, 
many advances have been made in the surgical reconstruction of the ACL and the 
disastrous total meniscectomy has been abandoned long ago. The role of new surgical 
techniques like double bundle ACL surgery still has to be found. 
Apart from the acellularization of tissues, the use of growth factors, additionally or alone, 
seems to be a very promising option in improving the long- term results. Especially in 
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even further improve the results. Maybe the use of bioreactors producing adequate 
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7. Conclusion 
Tissue engineering provides a lot of possibilities for improving tendon or meniscus 
scaffolds. Especially, the acellularization process with following cell seeding might be a very 
effective way of improving incorporation and remodelling processes as well as avoiding the 
cell-based immune reactions, which may be partially responsible for the deterioration of the 
allografts over the years. We have shown that the treatment of tendons or meniscus samples 
with the solvent SDS produces cell- free constructs. Despite acellularization, the extracellular 
matrix remains widely intact and the biomechanical properties remain unaltered. Whether 
the acellularization and the seeding will be successful in the long term has still to be shown 
in further animal models. Only then will human application be possible and improve 
operative treatment for our patients.  
Big efforts have been made during the last years in vitro and in vivo and we believe that the 
tissue engineering of tendons and menisci samples might play a crucial role in the future of 
orthopaedic surgery. 
 
8. References 
Allman AJ, McPherson TB, Badylak SF, Merrill LC, Kallakury B, Sheehan C, Raeder RH, 
Metzger DW (2001). Xenogeneic extracellular matrix grafts elicit a TH2-restricted 
immune response, Transplantation 71, pp. 1631–1640 
Allaire R; Muriuki M; Gilbertson L; Harner CD (2008). Biomechanical consequences of a tear 
of the posterior root of the medial meniscus. Similar to total meniscectomy. J Bone 
Joint Surg Am; Vol. 90; no. 9; 1922-31. 
Armour AD; Fish JS; Woodhouse KA; Semple JL (2006). A comparison of human and 
porcine acellularized dermis: interactions with human fibroblasts in vivo. Plast 
Reconstr Surg; Vol. 117; No. 3, 845 
Arnoczky SP; Warren RF (1983). The microvasculature of the meniscus and its response to 
injuries. An experimental study in the dog. American Journal of Sports Medicine. 
Vol. 11, No. 3, 131- 41.  
Arnoczky SP (1983). Anatomy of the anterior cruciate ligament. Clin Orthop Relat Res.Vol 
172,19-25 
Aune A; Holm I; Risberg M; Jensen H; Steen H (2001). Four- strand hamstring tendon 
autograft compared with patellar tendon- bone autograft for anterior cruciate 
ligament reconstruction. American Journal of Sports Medicine; Vol. 32; 1639- 43 
Badylak SF (2007). Review. The extracellular matrix as a biologic scaffold material. 
Biomaterials. Vol. 28, No. 25, 3587-93 
Badylak SF, Freytes DO, Gilbert TW (2009). Extracellular matrix as a biological scaffold 
material: Structure and function. Acta Biomater.  Vol. 5, No. 1, 1-13.  
Badylak SF; Tullius R; Kokini K; Shelbourne KD; Klootwyk T; Voytik SL; Kraine MR; 
Simmons C (1995). The use of xenogeneic small intestinal submucosa as a 
biomaterial for Achilles tendon repair in the dog model. J Biomed Mater Res; Vol. 
29; No 8; 977 
Barber FA; Herbert MA; Coons DA (2006): Tendon augmentation grafts: biomechanical 
failure loads and failure patterns. Arthroscopy; Vol. 22; No. 5; 534-8 
Beard D; Anderson J; Davies S; Price A; Dodd C (2001). Hamstring vs. patella tendon for 
anterior cruciate ligament reconstruction: a randomised controlled trial. Knee; Vol. 
8; 45-50. 
Bellincampi LD, Closkey RF, Prasad R, Zawadsky JP, Dunn MG (1998).Viability of 
fibroblast-seeded ligament analogs after autogenous implantation. J Orthop Res; 
Vol. 16; No. 4; 414-20. 
Beattie AJ, Gilbert TW, Guyot JP, Yates AJ, Badylak SF. (2009). Chemoattraction of 
progenitor cells by remodeling extracellular matrix scaffolds. Tissue Eng Part A; 
Vol. 15; No. 5:1119-25. 
Bhrany AD; Beckstead BL; Lang TC; Farwell DG; Giachelli CM; Ratner BD (2006). 
Development of an oesophagus acellular matrix tissue scaffold. Tissue Eng; Vol. 12; 
319-30 
Bolland F, Korossis S, Wilshaw SP, Ingham E, Fisher J, Kearney JN, Southgate J (2007). 
Development and characterisation of a full-thickness acellular porcine bladder 
matrix for tissue engineering. Biomaterials. Vol. 28; No 6:1061-70 
Brown B; Lindberg K; Reing J; Stolz DB; Badylak SF (2006). The basement membrane 
component of biologic scaffolds derived from extracellular matrix. Tissue Eng; Vol. 
12; No. 3; 519 
Brown BN, Valentin JE, Stewart-Akers AM, McCabe GP, Badylak SF (2009). Macrophage 
phenotype and remodeling outcomes in response to biologic scaffolds with and 
without a cellular component. Biomaterials; Vol. 8:1482-91 
Brucker PU; Lorenz S; Imhoff AB (2006). Aperture fixation in arthroscopic anterior cruciate 
ligament double-bundle reconstruction. Arthroscopy; Vol. 22; No 11; 1250.e1-6 
Bryant AL; Pua YH; Clark RA (2009). Morphology of knee extension torque-time curves 
following anterior cruciate ligament injury and reconstruction. J Bone Joint Surg 
Am; Vol. 91; No. 6; 1424- 31 
Buck RE; Malinin T; Brown MD (1989). Bone transplantation and human immunodeficiency 
virus: an estimate of risk of AIDS. Clin Orthop, Vol. 240; No. 129 
Buma P; van Tienen T; Veth R (2007). The collagen meniscus implant. Expert Rev Med 
Devices; Vol. 4; No. 4; 507-16. Review 
Busam ML, Rue JP, Bach BR Jr.(2007). Fresh-frozen allograft anterior cruciate ligament 
reconstruction.Clin Sports Med. Vol. 26; No.4:607-23 
Carey JL; Dunn WR; Dahm DL; Zeger SL; Spindler KP (2009). A systematic review of 
anterior cruciate ligament reconstruction with autograft compared with allograft. J 
Bone Joint Surg Am; Vol. 91; No. 9; 2242-50 
Cartmell JS; Dunn MG. (2000). Effect of chemical treatments on tendon cellularity and 
mechanical properties. J Biomed Mater Res. 2000 Jan;49(1):134-40.  
Cartmell JS, Dunn MG. Development of cell-seeded patellar tendon allografts for anterior 
cruciate ligament reconstruction. Tissue Eng. 2004 Jul-Aug;10(7-8):1065-75 
Cebotari S; Lichtenberg A; Tudorache I; Hilfiker A; Mertsching H; Leyh R; Breymann T; 
Kallenbach K; Maniuc L; Batrinac A; Repin O; Maliga O; Ciubotaru A; Haverich A 
(2006). Clinical application of tissue engineered human heart valves using 
autologous progenitor cells. Circulation; Vol. 14; No.1; 1132 
Chen N, Field EH. (1995). Enhanced type 2 and diminished type 1 cytokines in neonatal 
tolerance, Transplantation, Vol. 59: 933–941 
www.intechopen.com
Tissue engineering of the anterior cruciate ligament and meniscus using acellularized scaffolds 453
7. Conclusion 
Tissue engineering provides a lot of possibilities for improving tendon or meniscus 
scaffolds. Especially, the acellularization process with following cell seeding might be a very 
effective way of improving incorporation and remodelling processes as well as avoiding the 
cell-based immune reactions, which may be partially responsible for the deterioration of the 
allografts over the years. We have shown that the treatment of tendons or meniscus samples 
with the solvent SDS produces cell- free constructs. Despite acellularization, the extracellular 
matrix remains widely intact and the biomechanical properties remain unaltered. Whether 
the acellularization and the seeding will be successful in the long term has still to be shown 
in further animal models. Only then will human application be possible and improve 
operative treatment for our patients.  
Big efforts have been made during the last years in vitro and in vivo and we believe that the 
tissue engineering of tendons and menisci samples might play a crucial role in the future of 
orthopaedic surgery. 
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